1.Optimized expression, preparation of human papillomavirus 16 L2E7 fusion protein and its inhibitory effect on tumor growth in mice.
Yunshui JIANG ; Jianbo LI ; Meng GAO ; Jiao REN ; Sufeng JIN ; Gang CHEN ; Jie WU ; Fangcheng ZHUANG ; Houwen TIAN
Chinese Journal of Biotechnology 2015;31(4):566-576
HPV16 L2E7 is a fusion protein used for therapeutical vaccine targeting HPV virus. To increase its expression in Escherichia coli, we optimized the codon usage of HPV16 l2e7 gene based on its codon usage bias. The optimized gene of HPV16 sl2e7 was cloned into three different vectors: pGEX-5X-1, pQE30, ET41a, and expressed in JM109, JM109 (DE3) and BL21 (DE3) lines separately. A high expression line was selected with pET41a vector in BL21 (DE3) cells. After optimization of the growth condition, including inoculation amount, IPTG concentration, induction time and temperature, the expression level of HPV16 L2E7 was increased from less than 10% to about 28% of total protein. HPV16 L2E7 protein was then purified from 15 L culture by means of SP Sepharose Fast Flow, Q Sepharose Fast Flow and Superdex 200 pg. After renaturing, HPV16 L2E7 protein with ≥ 95% purity was achieved, which was confirmed via SDS-PAGE gel and Western blotting. The combined use of purified HPV16 L2E7 and CpG helper has shown clear inhibition of tumor growth in mice injected with tumor cells, with six out of eight mice shown no sign of tumor. This study lays a solid foundation for a new pipeline of large-scale vaccine production.
Animals
;
Capsid Proteins
;
biosynthesis
;
Codon
;
Electrophoresis, Polyacrylamide Gel
;
Escherichia coli
;
Genetic Vectors
;
Human papillomavirus 16
;
Mice
;
Neoplasms, Experimental
;
prevention & control
;
Oncogene Proteins, Viral
;
biosynthesis
;
Papillomavirus E7 Proteins
;
biosynthesis
;
Papillomavirus Vaccines
;
therapeutic use
;
Recombinant Fusion Proteins
;
biosynthesis
2.Efficacy of different doses of urapidil in preventing pituitrin-induced cardiovascular responses in patients undergoing laparoscopic myomectomy
Tieying SONG ; Pengyu MA ; Guohua GAO ; Yanchao YANG ; Chunping WANG ; Jian YA ; Bo JIANG ; Kun MA ; Yunshui PENG
Chinese Journal of Anesthesiology 2011;31(7):792-794
ObjectiveTo evaluate the efficacy of different dones of urapidil in preventing pituitrin-induced cardiovascular responses in patients undergoing laparoscopic myomectomy.MethodsSixty ASA Ⅰ or Ⅱ patients,aged 27-41 yr,weighing 55-65 kg,scheduled for elective laparoscopic myomectomy under general anesthesia,were randonly divided into 4 groups (n =15 each):control group (group C) and urapidil 0.3,0.5 and 0.8 mg/kg groups (groups U1-3).Urapidil 0.3,0.5 and 0.8 mg/kg were injected intravenously in U1-3 groups respectively,while normal saline 5 ml was given in group C.The mixture of pituitrin 6 U and normal saline 20 ml was injected into the site of hysteromyoma 5 min later.The operation was then started.BIS value was maintained at 45-55.The occurrence of cardiovascular responses was recorded.ResultsThe incidences of cardiovascular responses were 100%,67%,40% and 20% in groups C and U1-3 respectively.The incidence of cardiovascular responses was significantly lower in groups U1-3 than in group C,and in groups U2.3 than in group U1 ( P < 0.01 ).There was no significant difference in the incidence of cordiovascular responses between U2 and U3 groups (P > 0.05).ConclusionUrapidil can prevent pituitrin-induced cardiovascular responses in patients undergoing laparoscopic myomectomy and the optimal dose is 0.5 mg/kg.
3.A study on the association between exposure of uric acid accumulation and risks of acute pancreatitis
A'fang SU ; Guangjian LI ; Yunshui ZHANG ; Xiujuan ZHAO ; Shouling WU ; Xiaozhong JIANG
The Journal of Practical Medicine 2024;40(14):2009-2014
Objective To investigate the correlation between exposure of uric acid accumulation and the risks of acute pancreatitis(AP)in the population in Kailuan Group.Methods A prospective study was performed based on thesubjects receiving annual physical examination during 2006 to 2010 in Kailuan Group.All of them had no AP history but had complete data on UA.The starting point of follow-up was when the subjects completed the health examination in 2010,and the end point was new AP events,deaths or the end of follow-up(2021-12-31).Exposure of uric acid accumulation(cumUA)was calculated according to the average values of uric acid measured in each two consecutive physical examinations and the intervalbetween these two consecutive physical examinations.The cumulative incidences of AP indifferent subgroups(determined by the quartile of cumUA)were described using Kaplan-Meier product limit-method and compared by log-rank test.Multivariate Cox proportional hazards regression model was used to analyze the impacts of different cumUA subgroups on new occurrence of AP events.Results A total of 55,799 subjects were included in this study.The subjects were divided into four groups according to the quartile of cumUA.Sex ratio,average age,BMI,systolic blood pressure(SBP),diastolic blood pressure(DBP),FPG,TC,TG,LDL-C,HDL-C,smoking,alcohol consumption,education≥9 years,physical exercise,history of hypertension,and history of cholelithiasis differed significantly among the groups(P<0.05),there was no difference in diabetes history among the 4 groups(P=0.30).153 patients developed AP during an average follow-up of(10.52±1.75)years,the incidence rates were 1.65,2.76,2.13 and 3.96 per 10 000 person-year in the Q1,Q2,Q3and Q4,respectively(P<0.01).After adjusting sex,age,TC,TG,eGFR,smoking,alcohol consumption,education,physical activity,and history of hypertension,diabetes,or cholelithiasis,Multivariate analysis showed a significantly increased risk in Q4(HR=1.77,95%CI:1.07~2.92)as comparing with Q1.After excluding deaths during the follow-up period,Multivariate Cox regression analysis was performed again in Q4 HR=1.75(95%CI:1.04~2.95).Conclusions With the increase of cumUA exposure,both morbidity and risk of AP occur-rence have the tendency of rising.
4.Influence of serum cumulative triglyceride exposure on the risk of acute pancreatitis
Afang SU ; Xiaozhong JIANG ; Yunshui ZHANG ; Shouling WU ; Guangjian LI
Journal of Clinical Hepatology 2024;40(12):2492-2498
ObjectiveTo investigate the association between cumulative triglyceride (cumTG) exposure and the risk of acute pancreatitis (AP). MethodsA prospective study was conducted for a cohort of 56 883 workers from Kailuan Group who participated in annual physical examination for three consecutive times in 2006-2010 (2006, 2008, and 2010) and had complete TG data without the medical history of AP. According to the quartiles of cumTG calculated, the subjects were divided into four groups (Q1, Q2, Q3, and Q4 groups), and general information was compared between the two groups. A one-way analysis of variance was used for comparison of normally distributed continuous data between multiple groups, and the Kruskal-Wallis H test was used for comparison of continuous data with skewed distribution between multiple groups; the chi-square test was used for comparison of categorical data between groups. The Kaplan-Meier method was used to plot the survival curve and calculate the cumulative incidence rate of AP, and the Log-rank test was used for comparison between groups; the Cox regression model was used to analyze the effect of different cumTG levels on new-onset AP events. ResultsAfter follow-up for 10.51±1.76 years, there were 158 AP events in total, with a total incidence density of 2.64 per 10 000 person-years, and the number of cases and incidence density in the Q1, Q2, Q3, and Q4 groups were 29 cases (1.93 per 10 000 person-years), 34 cases (2.27 per 10 000 person-years), 30 cases (2.01 per 10 000 person-years), and 65 cases (4.37 per 10 000 person-years). The Log-rank test showed that there was a significant difference in cumulative incidence rate between groups (χ2=22.41, P<0.001). The multivariate Cox regression analysis showed that compared with the Q1 group, the Q4 group had a significantly higher risk of AP (hazard ratio [HR]=1.94, 95% confidence interval [CI]: 1.20 — 3.13, P=0.01). Compared with cumulative triglyceride exposure for 0 year, cumulative triglyceride exposure for 4 and 6 years significantly increased the risk of AP, with an HR value of 2.04 (95%CI: 1.26 — 3.30, P<0.01) and 3.20 (95%CI: 1.98 — 5.17, P<0.01), respectively. After exclusion of the AP cases that occurred during the 2-year follow-up, the repeated multivariate Cox regression analysis showed that the Q4 group had an HR value of 1.96 (95%CI: 1.23 — 3.12, P<0.01) for the onset of AP, and after exclusion of the death cases during follow-up, the repeated multivariate Cox regression analysis showed that the Q4 group had an HR value of 1.85 (95%CI: 1.10 — 3.14, P<0.05) for the onset of AP. ConclusionThe incidence rate and risk of AP tend to increase with the increase in cumTG exposure.